Biomarkers in thrombosis and hemostasis Post March 10,2017
Biomarkers - Publika Dev
Biomarkers allow detecting abnormal activities in blood, very early in the pathological process development. They are indicators of blood activation, which increases the risk of developping thromboembolic events. Many markers concern activation peptides, or released proteins withvery short half lives (minutes rage). The most popular thrombosis biomarker is DDimer, due to its lasting generation when fibrinoformation occurs (generated as long as clot lysis occurs, for days or weeks), and its average half life is of about 6 hours.